MENU
CSCI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
COSCIENS Biopharma (CSCI) Ownership - Who owns COSCIENS Biopharma?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.51M
P/E Ratio
N/A
Total Cash
20M
Projected Growth
N/A
Total Debt
1.62M
Revenue
7.6M
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash/Share
6.40
Total Debt/Equity
N/A
Revenue/Share
3.36 USD as % of share price
Fundamentals
CSCI
Capitalization
8.51M
P/E Ratio
N/A
Risk (Beta)
0.75
Dividend Yield
N/A
Total Cash
20M
Total Cash/Share
6.40
Total Debt
1.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.36%
Revenue
7.6M
ROE
N/A
Book Value
20M
P/B Ratio
0.42
Cash Flow
N/A
Earnings
-4.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22.4M
Current Ratio
3.46
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-9.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
51.15
Revenue To Assets
-29.70
Shares Held By Institutions
3.39K
Shares Outstanding - Current
3.12M
Total Liabilities
23.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
55.382
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A